Glass House today announced that it has retained Matt Murphy as an advisor on DEA compliance as it relates to instituting regulations related to interstate commerce and the export of medical cannabis compliant with Schedule III regulatory requirements.
Murphy is the founder and president of Pharma Compliance Group (PCG), an advisory firm specializing in providing compliance expertise to pharmaceutical companies assisting them to comply with the regulations related to the Controlled Substances Act (CSA) and the Code of Federal Regulations (CFR), enforced by the DEA, as it pertains to pharmaceutical drug manufacturing, wholesale drug distribution and retail pharmacy operations. Prior to founding PCG, he had a 26-year career with the Drug Enforcement Administration (DEA) as a special agent and regulatory subject matter expert. He served as the Chief of Pharmaceutical Investigations for the DEA and retired as the Assistant Special Agent in Charge in the New England Field Division.
Additionally, from 2017 through 2021, Murphy was the Chief Compliance Officer for Khiron Life Sciences (Khiron), the first licensed vertically integrated cannabis operator in Colombia and an early supplier of cannabis flower and extracts to Germany and the UK. During his tenure, he developed Khiron’s compliance and seed to sale tracking program, enabling the company to become Colombia’s first medical cannabis producer to comply with DEA security and compliance protocols.
“Given our scale and low-cost production capabilities, Glass House is uniquely qualified to opportunistically supply cannabis markets outside the state of California and the United States. As we progress in developing new sales channels, there are few, if any people, as uniquely qualified as Matt to assist us with the development of new regulatory compliance processes,” said Kyle Kazan, co-founder, chairman and CEO of Glass House, in a statement.
“Having lived it for more than two decades, Matt knows the inner workings of the DEA and controlled substance and pharmaceutical grade compliance and while at Khiron he experienced the inner-workings of compliant cannabis production and distribution. At Khiron, Matt achieved much of what we are trying to do, implementing systems to enable the secure distribution of products out of Colombia and into Europe. As we aim to develop and implement track and trace processes that comply with existing closed-loop California systems and enable us to distribute outside the state, we will lean on Matt’s experience and expertise. Furthermore, we hope for Matt to be a resource to state and federal regulators providing a pathway to better understand and implement viable regulatory frameworks resulting in expedited opportunities for interstate commerce and US cannabis export."
"As we look ahead, we aim to compliantly grow cannabis for sale in whatever markets offer us the highest possible price. It is clear that European and U.S. customers outside our home state want our and other California product and our goal remains to deliver it to them as quickly as possible.”
